logo
13:34 Feb 10

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
13504.00
-386.00 (-2.78%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Neuland Laboratories Ltd. Financials

Neuland Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
13504.00
-386.00 (-2.78%)
13:34 Feb 10
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

24/100
Expensive Valuation

Technical

47/100
Technically Neutral

Strength

5

Weakness

6

Opportunity

1

Threats

0

17.06 %

ROE %

11.93 %

ROA %

139.62

EPS

1,181.32

BVPS

17.61 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
936.91 951.08 1191.2 1558.58 1476.84
Operating Expenses +
790.09 808.45 919.35 1095.99 1153.57
Raw Material
439.66 437.55 487.74 632.43 574.81
Increase Decrease in Cost
-1.24 -15.41 -9.51 -55.14 12.83
Other Manufacturing Expense
120.29 131.36 135.56 156.51 162.87
Employee Cost
149.74 182.47 201.79 257.06 272
Miscellaneous Expenses
81.64 72.48 103.77 105.13 131.06
Operating Profit
146.82 142.63 271.85 462.59 323.27
Other Income
16.1 2.08 9.75 12.54 20.51
Depreciation
39.68 49.04 52.78 59.7 65.55
Interest
17.9 13.5 13.07 14 8.3
Profit before tax and exceptio..
105.33 82.16 215.75 401.44 269.93
Exceptional Items
0 0 0 0 76.4
PBT
105.33 82.16 215.75 401.44 346.33
Provision for Taxation
24.7 18.34 52.23 101.36 86.22
Net Profit
80.63 63.82 163.52 300.08 260.11
NET Profit after MI
80.63 63.82 163.52 300.08 260.11
EPS
62.85 49.74 127.45 233.89 202.74
Operating Profit Margin (%)
15.67 15 22.82 29.68 21.89
Net Profit Margin (%)
8.61 6.71 13.73 19.25 17.61

Neuland Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: